- Home
- EOS vs BBNX Comparison
EOS vs BBNX Comparison
Compare EOS & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EOS | BBNX |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | EOS | BBNX |
|---|---|---|
| Price | $22.97 | $30.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $28.09 |
| AVG Volume (30 Days) | 84.1K | ★ 486.0K |
| Earning Date | 01-01-0001 | 10-28-2025 |
| Dividend Yield | ★ 6.80% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $88,570,000.00 |
| Revenue This Year | N/A | $52.13 |
| Revenue Next Year | N/A | $36.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.01 |
| 52 Week Low | $15.62 | $8.89 |
| 52 Week High | $20.63 | $32.71 |
Technical Indicators
Market Signals| Indicator | EOS | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 50.67 | 59.65 |
| Support Level | $22.74 | $27.87 |
| Resistance Level | $23.05 | $32.71 |
| Average True Range (ATR) | 0.39 | 2.04 |
| MACD | 0.10 | -0.14 |
| Stochastic Oscillator | 93.95 | 62.01 |
Price Performance
Historical ComparisonAbout EOS Eaton Vance Enhance Equity Income Fund II
Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.